Healthcare Services

Cardiogenomics Market Future Outlook Showing Expansion Toward $3.57 Billion by 2030

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Cardiogenomics Market Expected To Change Between 2026 And 2030?

The cardiogenomics market size has seen rapid expansion in recent years. It is anticipated to expand from $1.74 billion in 2025 to $2.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.7%. The market’s growth during the preceding period can be ascribed to factors such as the increasing prevalence of cardiovascular diseases, advancements in genetic testing technologies, a rise in clinical genomics research, broader availability of molecular diagnostics, and growing awareness of inherited heart conditions.

The cardiogenomics market is projected to experience substantial expansion over the upcoming years, set to reach $3.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This anticipated growth during the forecast period stems from factors such as heightened demand for individualized cardiac care, the broadening of precision medicine programs, increased funding for genomic investigations, the expanding use of AI-powered genomic analysis, and greater incorporation of genomics into standard cardiology procedures. Key trends identified for the forecast timeframe encompass the wider acceptance of genetic risk profiling within cardiology, the growing application of next-generation sequencing in studies of heart disease, the increasing amalgamation of bioinformatics platforms, the development of individualized cardiovascular treatment strategies, and a stronger emphasis on proactive genomic screening.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28156&type=smp

Which Economic Or Industry Drivers Are Impacting The Cardiogenomics Market?

The rising need for personalized medicine is anticipated to fuel expansion in the cardiogenomics market. Personalized medicine involves a healthcare strategy that customizes prevention, diagnosis, and treatment based on an individual’s genetic makeup, environmental factors, and lifestyle. This surge in personalized medicine is propelled by advancements in genomics, which allow for a deeper comprehension of individual genetic variations, leading to more precise, targeted therapies that enhance patient outcomes and minimize experimental approaches. Cardiogenomics complements personalized medicine by applying genetic insights to customize the prevention, diagnosis, and treatment of cardiovascular diseases according to a person’s unique genetic profile. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the FDA sanctioned 16 new personalized treatments for rare disease patients, a significant rise from six in 2022. Among these newly approved personalized treatments for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the growing demand for personalized medicine is stimulating the expansion of the cardiogenomics market.

How Is The Cardiogenomics Market Structured Across Different Segments?

The cardiogenomics market covered in this report is segmented –

1) By Product Type: Testing Kits, Reagents, Instruments, Software, Services

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies

3) By Application: Congenital Heart Diseases, Cardiomyopathies, Arrhythmias, Coronary Artery Disease, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Testing Kits: PCR (Polymerase Chain Reaction) kits, Microarray kits, NGS (Next Generation Sequencing) kits

2) By Reagents: Enzymes, Probes, Buffers

3) By Instruments: Sequencers, Genotyping instruments, Microarray Scanners

4) By Software: Data Analysis Software, Reporting Platforms, Bioinformatics Tools

5) By Services: Genetic Testing Services, Counseling Services, Data Analysis Services

What Key Trends Are Influencing The Development Of The Cardiogenomics Market?

Key players within the cardiogenomics market are concentrating on developing advanced solutions, such as oncogenomics, to bolster early detection and individualized treatment for cancers associated with the cardiovascular system. Oncogenomics is defined as the investigation of genes linked to cancer and their mutations, providing insight into cancer development and progression, which aids in devising targeted therapies and custom treatment plans. For example, in April 2025, Fortis Healthcare Ltd., an India-based healthcare firm, inaugurated a Fortis Institute of Genomic Medicine in India, aiming to propel genetic research and personalized medicine. This institute reshapes patient care by allowing for early disease identification, accurate diagnoses, and personalized treatment across various specialties, including oncology, cardiology, and neurology. It also enables focused therapies, improves the results of treatments, and supports preventive care for inherited conditions. The institute’s primary goal is to foster precision medicine through a collaborative team and groundbreaking technologies, ultimately delivering more personalized and effective healthcare to Indian patients.

Which Major Players Dominate The Cardiogenomics Market?

Major companies operating in the cardiogenomics market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics Incorporated, Illumina Inc., QIAGEN N.V., Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, GeneDx Inc., Helix OpCo LLC, SOPHiA GENETICS SA, Baylor Genetics, Blueprint Genetics, Novogenia GmbH, Veritas Genetics, Dante Genomics, Gene by Gene Ltd., GENinCode Plc., UAB Cardiogenomics Clinic

Read the full cardiogenomics market report here:

https://www.thebusinessresearchcompany.com/report/cardiogenomics-global-market-report

What Are The Top-Performing Regions Within The Cardiogenomics Market?

North America was the largest region in the cardiogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiogenomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28156&type=smp

Browse Through More Reports Similar to the Global Cardiogenomics Market 2026, By The Business Research Company

Cardiac Valve Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Cardiac Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Structural Heart Global Market Report

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795